{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:32:48Z","timestamp":1793795568282,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00261-020-02582-8","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:02:56Z","timestamp":1590145376000},"page":"2476-2484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The abrupt pancreatic duct cutoff sign on MDCT and MRI"],"prefix":"10.1007","volume":"45","author":[{"given":"Andrew","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Serhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Lopes Vendrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinadh","family":"Komanduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne M.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Nikolaidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9506-9411","authenticated-orcid":false,"given":"Frank H.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"issue":"1","key":"2582_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69 (1):7-34. https:\/\/doi.org\/10.3322\/caac.21551","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2582_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00261-017-1308-z","volume":"43","author":"CM Lindquist","year":"2018","unstructured":"Lindquist CM, Miller FH, Hammond NA, Nikolaidis P (2018) Pancreatic cancer screening. Abdom Radiol (NY) 43 (2):264-272. https:\/\/doi.org\/10.1007\/s00261-017-1308-z","journal-title":"Pancreatic cancer screening. Abdom Radiol (NY)"},{"issue":"2","key":"2582_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2214\/AJR.18.20017","volume":"212","author":"A Garces-Descovich","year":"2019","unstructured":"Garces-Descovich A, Morrison TC, Beker K, Jaramillo-Cardoso A, Moser AJ, Mortele KJ (2019) DWI of pancreatic ductal adenocarcinoma: a pilot study to estimate the correlation With metastatic disease potential and overall survival. AJR Am J Roentgenol 212 (2):323-331. https:\/\/doi.org\/10.2214\/AJR.18.20017","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"2582_CR4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"DP Ryan","year":"2014","unstructured":"Ryan DP, Hong TS, Bardeesy N (2014) Pancreatic adenocarcinoma. N Engl J Med 371 (11):1039-1049. https:\/\/doi.org\/10.1056\/NEJMra1404198","journal-title":"N Engl J Med"},{"key":"2582_CR5","doi-asserted-by":"publisher","unstructured":"Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, et al (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230 (6):776\u2013782; discussion 782\u2013774. https:\/\/doi.org\/10.1097\/00000658-199912000-00006","DOI":"10.1097\/00000658-199912000-00006"},{"issue":"14","key":"2582_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/jama.2013.279201","volume":"310","author":"H Oettle","year":"2013","unstructured":"Oettle H, Neuhaus P, Hochhaus A, Hartmann JT, Gellert K, Ridwelski K, et al (2013) Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA 310 (14):1473-1481. https:\/\/doi.org\/10.1001\/jama.2013.279201","journal-title":"JAMA"},{"issue":"12","key":"2582_CR7","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/1097-0142(19870615)59:12<2006::aid-cncr2820591206>3.0.co;2-b","volume":"59","author":"HO Douglass","year":"1987","unstructured":"Douglass HO, Nava HR, et al (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer 59 (12):2006-2010. https:\/\/doi.org\/10.1002\/1097-0142(19870615)59:12<2006::aid-cncr2820591206>3.0.co;2-b","journal-title":"Gastrointestinal Tumor Study Group. Cancer"},{"issue":"5","key":"2582_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1634\/theoncologist.2012-0435","volume":"18","author":"JE Faris","year":"2013","unstructured":"Faris JE, Blaszkowsky LS, McDermott S, Guimaraes AR, Szymonifka J, Huynh MA, et al (2013) FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Oncologist 18 (5):543-548. https:\/\/doi.org\/10.1634\/theoncologist.2012-0435","journal-title":"Oncologist"},{"issue":"6","key":"2582_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S1470-2045(16)00172-8","volume":"17","author":"M Suker","year":"2016","unstructured":"Suker M, Beumer BR, Sadot E, Marthey L, Faris JE, Mellon EA, et al (2016) FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol 17 (6):801-810. https:\/\/doi.org\/10.1016\/S1470-2045(16)00172-8","journal-title":"Lancet Oncol"},{"issue":"1","key":"2582_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/SLA.0000000000000867","volume":"261","author":"CR Ferrone","year":"2015","unstructured":"Ferrone CR, Marchegiani G, Hong TS, Ryan DP, Deshpande V, McDonnell EI, et al (2015) Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg 261 (1):12-17. https:\/\/doi.org\/10.1097\/SLA.0000000000000867","journal-title":"Ann Surg"},{"key":"2582_CR11","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, et al (2016) Pancreatic cancer. Nat Rev Dis Primers 2:16022. https:\/\/doi.org\/10.1038\/nrdp.2016.22","journal-title":"Pancreatic cancer. Nat Rev Dis Primers"},{"issue":"1","key":"2582_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V (2019) Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol 10 (1):10-27. https:\/\/doi.org\/10.14740\/wjon1166","journal-title":"World J Oncol"},{"issue":"1","key":"2582_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1148\/radiol.10100015","volume":"257","author":"JH Kim","year":"2010","unstructured":"Kim JH, Park SH, Yu ES, Kim MH, Kim J, Byun JH, et al (2010) Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology 257 (1):87-96. https:\/\/doi.org\/10.1148\/radiol.10100015","journal-title":"Radiology"},{"issue":"3","key":"2582_CR14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1148\/radiol.2243011284","volume":"224","author":"RW Prokesch","year":"2002","unstructured":"Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB, Jr. (2002) Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 224 (3):764-768. https:\/\/doi.org\/10.1148\/radiol.2243011284","journal-title":"Radiology"},{"issue":"2","key":"2582_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1148\/radiol.11101133","volume":"259","author":"SH Yoon","year":"2011","unstructured":"Yoon SH, Lee JM, Cho JY, Lee KB, Kim JE, Moon SK, et al (2011) Small (<\/= 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology 259 (2):442-452. https:\/\/doi.org\/10.1148\/radiol.11101133","journal-title":"Radiology"},{"issue":"4","key":"2582_CR16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2214\/ajr.182.4.1820897","volume":"182","author":"S Gangi","year":"2004","unstructured":"Gangi S, Fletcher JG, Nathan MA, Christensen JA, Harmsen WS, Crownhart BS, et al (2004) Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol 182 (4):897-903. https:\/\/doi.org\/10.2214\/ajr.182.4.1820897","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"2582_CR17","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.2214\/AJR.17.17963","volume":"209","author":"SW Kim","year":"2017","unstructured":"Kim SW, Kim SH, Lee DH, Lee SM, Kim YS, Jang JY, et al (2017) Isolated main pancreatic duct dilatation: ct differentiation between benign and malignant causes. AJR Am J Roentgenol 209 (5):1046-1055. https:\/\/doi.org\/10.2214\/AJR.17.17963","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2582_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cgh.2018.04.065","volume":"17","author":"JE Corral","year":"2019","unstructured":"Corral JE, Mareth KF, Riegert-Johnson DL, Das A, Wallace MB (2019) Diagnostic yield from screening asymptomatic individuals at high risk for pancreatic cancer: a meta-analysis of cohort studies. Clin Gastroenterol Hepatol 17 (1):41-53. https:\/\/doi.org\/10.1016\/j.cgh.2018.04.065","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"2582_CR19","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.ejrad.2015.05.012","volume":"84","author":"KM Jang","year":"2015","unstructured":"Jang KM, Kim SH, Kim YK, Song KD, Lee SJ, Choi D (2015) Missed pancreatic ductal adenocarcinoma: assessment of early imaging findings on prediagnostic magnetic resonance imaging. Eur J Radiol 84 (8):1473-1479. https:\/\/doi.org\/10.1016\/j.ejrad.2015.05.012","journal-title":"Eur J Radiol"},{"key":"2582_CR20","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-08040-0","author":"M Sandini","year":"2019","unstructured":"Sandini M, Negreros-Osuna AA, Qadan M, Hank T, Patino M, Ferrone CR, et al (2019) Main pancreatic duct to parenchymal thickness ratio at preoperative imaging is associated with overall survival in upfront resected pancreatic cancer. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-019-08040-0","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2582_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1097\/MPA.0b013e31827305b8","volume":"42","author":"MA Eloubeidi","year":"2013","unstructured":"Eloubeidi MA, Luz LP, Tamhane A, Khan M, Buxbaum JL (2013) Ratio of pancreatic duct caliber to width of pancreatic gland by endosonography is predictive of pancreatic cancer. Pancreas 42 (4):670-679. https:\/\/doi.org\/10.1097\/MPA.0b013e31827305b8","journal-title":"Pancreas"},{"issue":"2","key":"2582_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.12865\/CHSJ.43.02.05","volume":"43","author":"MI Costache","year":"2017","unstructured":"Costache MI, Costache CA, Dumitrescu CI, Tica AA, Popescu M, Baluta EA, et al (2017) Which is the best imaging method in pancreatic adenocarcinoma diagnosis and staging - CT, MRI or EUS? Curr Health Sci J 43 (2):132-136. https:\/\/doi.org\/10.12865\/CHSJ.43.02.05","journal-title":"Curr Health Sci J"},{"issue":"1","key":"2582_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2214\/AJR.05.1005","volume":"187","author":"T Ichikawa","year":"2006","unstructured":"Ichikawa T, Erturk SM, Motosugi U, Sou H, Iino H, Araki T, et al (2006) High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol 187 (1):181-184. https:\/\/doi.org\/10.2214\/AJR.05.1005","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"2582_CR24","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1136\/gut.51.6.849","volume":"51","author":"D Malka","year":"2002","unstructured":"Malka D, Hammel P, Maire F, Rufat P, Madeira I, Pessione F, et al (2002) Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 51 (6):849-852. https:\/\/doi.org\/10.1136\/gut.51.6.849","journal-title":"Gut"},{"key":"2582_CR25","unstructured":"Balakrishnan V, Unnikrishnan AG, Thomas V, Choudhuri G, Veeraraju P, Singh SP, et al (2008) Chronic pancreatitis. A prospective nationwide study of 1,086 subjects from India. JOP 9 (5):593\u2013600"},{"issue":"9","key":"2582_CR26","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ajg.2017.218","volume":"112","author":"J Kirkegard","year":"2017","unstructured":"Kirkegard J, Mortensen FV, Cronin-Fenton D (2017) Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis. Am J Gastroenterol 112 (9):1366-1372. https:\/\/doi.org\/10.1038\/ajg.2017.218","journal-title":"Am J Gastroenterol"},{"key":"2582_CR27","doi-asserted-by":"publisher","unstructured":"Lopes Vendrami C, Shin JS, Hammond NA, Kothari K, Mittal PK, Miller FH (2019) Differentiation of focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma. Abdominal Radiology [epub ahead of print]. https:\/\/doi.org\/10.1007\/s00261-019-02210-0","DOI":"10.1007\/s00261-019-02210-0"},{"key":"2582_CR28","doi-asserted-by":"publisher","unstructured":"Kothari K, Lopes Vendrami C, Kelahan LC, Shin JS, Mittal P, Miller FH (2019) Inflammatory mimickers of pancreatic adenocarcinoma. Abdominal Radiology [epub ahead of print]. https:\/\/doi.org\/10.1007\/s00261-019-02233-7","DOI":"10.1007\/s00261-019-02233-7"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-020-02582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-020-02582-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-020-02582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T23:19:30Z","timestamp":1621639170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-020-02582-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["2582"],"URL":"https:\/\/doi.org\/10.1007\/s00261-020-02582-8","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]},"assertion":[{"value":"22 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}